stock valuation of square pharmaceuticals

8/18/2019 Stock valuation of Square Pharmaceuticals

1/4

SQUARE Pharmaceuticals Limited

2.4 Company profile at a glance

SQUARE today symbolizes a name – a state of mind. But its journey to the growth

and prosperity has been no bed of roses. rom the in!eption in "#$%& it has today burgeoned

into one of the top line !onglomerates in Bangladesh. S'uare (harma!euti!als )td.& the

flagship !ompany& is holding the strong leadership position in the pharma!euti!al industry of

Bangladesh sin!e "#%$ and is now on its way to be!oming a high performan!e global player.

SQUARE (harma!euti!als )imited is the largest pharma!euti!al !ompany in Bangladesh and

it has been !ontinuously in the "st position among all national and multinational !ompaniessin!e "#%$. *t was established in "#$% and !on+erted into a publi! limited !ompany in "##".

,he sales turno+er of S() was more than ,a-a ""./ Billion 0US1 "/2.3" million4 with about

"/.25 mar-et share 0April 677#– 8ar!h 67"74 ha+ing a growth rate of about "/.365.

Looking beyond the horizon

SQUARE (harma!euti!als )imited has e9tended its range of ser+i!es towards the highway of

global mar-et. *t pioneered e9ports of medi!ines from Bangladesh in "#%3 and has been

e9porting antibioti!s and other pharma!euti!al produ!ts. ,his e9tension in business and

ser+i!es has manifested the !redibility of S'uare (harma!euti!als )imited.

Mission

:ur 8ission is to produ!e and pro+ide 'uality ; inno+ati+e health!are relief for people&

maintain stringently ethi!al standard in business operation also ensuring benefit to the

shareholders& sta-eholders and the so!iety at large.

Vision


2/4

)ast fi+e years share pri!e and di+idend of s'uare (harma!euti!als )imited

=ear A8( 0,-.4 >i+idend

67"7 "6.27 2.$

67"" "2#.23 2

67"6 "2/."" 6.$

67"2 "$3.6 6.$

67" 6$#.7$ 2

Average Rate o Return o SQUARE last ive years

At first we ha+e to !al!ulate the rate of return for ea!h year. ?ow to !al!ulate the rate of

return we ha+e to !al!ulate the di+idend yields in per!entage and the !apital gain@loss in

per!entage whi!h are shown below in ,able below

Rate o Return

,he rate of return on a share !onsists of its di+idend yield and the !apital gain in per!entage.,hus the rate of return of a share held for one year is gi+en by

Rate of Return >i+idend yield in one year 054 C Dapital ain in :ne =ear 054

=ear A8( 0,F4 >i+idend >i+idend

=ield

Dapital ain Rate of Return

67"7 "6.27 2.$6.%6 5 G G

67"" "2#.23 26."$ 5 "6."6 5 ".63 5

67"6 "2/."" 6.$".% 5 G 6.2 5 G 7.$7 5

67"2 "$3.6 6.$

".$# 5 "$.// 5 "3.6$ 5


3/4

67" 6$#.7$ 2"."/ 5 /.$/ 5 /$.36 5

,hus the a+erage rate of return is gi+en by


4/4

S!"# A$AL%S&S

Strengths

". Highly e9perien!ed senior e9e!uti+es.6. ood reputation with high image.2. ood growth rate.. Staff members.$. )ess employee turno+er.

!eaknesses

". ?onGa+ailability of high te!hnology.6. E+erything is not organized.

2. ,ime !onsuming de!ision ma-ing pro!ess.. )a!- of asset management and debt.$. 8inimum profit.

"''ortunities

". o+ernment support.6. Relationship with the finan!ers.2. Relationship with suppliers.

. Relationship with shareholders and publi!.$. >ifferent arena of produ!ts.

#hreats

". ,hreat of new produ!t entrants.6. *ndustry Ri+alry.2. Bargaining (ower of Suppliers.. Bargaining (ower of Buyers.$. ,hreat of Substitutes.

stock valuation of square pharmaceuticals

Documents